FDA Generic Biologics Policy May Be One Change Under McClellan
Executive Summary
FDA Commissioner-designate Mark McClellan appears to be open to establishing a generic approval system for biological products
You may also be interested in...
Generic Biologics Are Coming, Commissioner McClellan Tells MBC
Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council
Generic Biologics Are Coming, Commissioner McClellan Tells MBC
Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council
Generic Biologics: Xigris Approval Suggests Precedent For FDA, GPhA Says
FDA's analysis of manufacturing process changes for Xigris is the latest indication that some form of a generic biologics approval process is feasible, the Generic Pharmaceutical Association says